FIGO Stage IV and Age Over 55 Years as Prognostic Predicators in Patients With Metastatic Malignant Struma Ovarii

FIGO Stage IV and Age Over 55 Years as Prognostic Predicators in Patients With Metastatic Malignant Struma Ovarii

Introduction: Metastatic malignant struma ovarii (MSO) is an extremely rare disease that lacks treatment consensus and accurate prognosis. The objective of this study was to present the clinical, pathological, and treatment characteristics of metastatic MSO, while also investigate the overall surviv...

Full description

Bibliographic Details
Main Authors: Sijian Li, Tengyu Yang, Xiaoyan Li, Limeng Zhang, Honghui Shi, Ninghai Cheng, Jinghe Lang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Oncology
Subjects:
malignant struma ovarii
metastatic
treatment
prognosis
risk factors
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.584917/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.584917/full

Similar Items